Similar articles

• Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.

  Fedotin MS. Fedotin MS. Postgrad Med. 1993 Sep 1;94(3):38-40, 43-5. Postgrad Med. 1993. PMID: 8361941 Review.
• Peptic ulcer treatment today--is there a role for maintenance therapy?

  Breslin NP, O'Morain C. Breslin NP, et al. Ital J Gastroenterol Hepatol. 1997 Apr;29(2):116-21. Ital J Gastroenterol Hepatol. 1997. PMID: 9646190 No abstract available.
• Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.

  Park KN, Hahm JS, Kim HJ. Park KN, et al. Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S103-7. Eur J Gastroenterol Hepatol. 1994. PMID: 7735924 Clinical Trial.
• Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.

  Peura DA, Graham DY. Peura DA, et al. Am J Gastroenterol. 1994 Aug;89(8):1137-9. Am J Gastroenterol. 1994. PMID: 8053422 Review. No abstract available.
• Helicobacter pylori therapy: effect on peptic ulcer disease.

  Axon AT. Axon AT. J Gastroenterol Hepatol. 1991 Mar-Apr;6(2):131-7. doi: 10.1111/j.1440-1746.1991.tb01452.x. J Gastroenterol Hepatol. 1991. PMID: 1912418 Review. No abstract available.